Concepedia

David Acton

DA

11

Publications

432

Citations

10

H-Index

1983

Active since

Affiliations

AstraZeneca (United Kingdom)(Current)

University of St Andrews

University of California San Diego

AstraZeneca (France)

Salk Institute for Biological Studies

David Acton is an author at AstraZeneca (United Kingdom) specializing in medicine, pharmacology, and drug discovery.

Top concepts

Publications per year

1983–2023

11

Publications

11

Spinal Neuropeptide Y1 Receptor-Expressing Neurons Form an Essential Excitatory Pathway for Mechanical Itch

David Acton, Xiangyu Ren, Stefania Di Costanzo et al. · Cell Reports · 2019 · 103 citations · Full text

New classes of antibacterial oxazolidinones with C-5, methylene O-Linked heterocyclic side chains

Michael B. Gravestock, David Acton, Michael J Betts et al. · Bioorganic & Medicinal Chemistry Letters · 2003 · 59 citations

, , +7

Discovery of AZD3514, a small-molecule androgen receptor downregulator for treatment of advanced prostate cancer

Robert H. Bradbury, David Acton, Nicola Broadbent et al. · Bioorganic & Medicinal Chemistry Letters · 2013 · 51 citations · Full text

, , +7

Small-molecule androgen receptor downregulators as an approach to treatment of advanced prostate cancer

Robert H. Bradbury, Neil J. Hales, Alfred A. Rabow et al. · Bioorganic & Medicinal Chemistry Letters · 2011 · 44 citations

, , +7

Tricyclic triarylethylene antiestrogens: dibenz[b,f]oxepins, dibenzo[b,f]thiepins, dibenzo[a,e]cyclooctenes, and dibenzo[b,f]thiocins

David Acton, G. C. Hill, Brian S. Tait · Journal of Medicinal Chemistry · 1983 · 37 citations

, , +18

Rows per page

1–5 of 11